Clinical Trial Update: Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating salvage therapeutic radiation with enzalutamide and androgen deprivation therapy in men with recurrent prostate cancer; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ADT (androgen deprivation therapy) (androgen deprivation therapy)
• Enzalutamide (enzalutamide)

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-03-20